CGEM vs HSHP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CGEM · Cullinan Therapeutics$11.31 ▲ 4.72%
HSHP · Himalaya Shipping$15.43 ▲ 3.28%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CGEM +52.0%
- HSHP +114.7%
Head to head
| Metric | CGEM | HSHP |
|---|---|---|
| Price | $11.31 | $15.43 |
| Change today | ▲ 4.72% | ▲ 3.28% |
| Market cap | $727.85M | $727.83M |
| Return, 3 months | -38.1% | +3.6% |
| Return, year to date | +9.3% | +86.6% |
| Return, 1 year | +57.3% | +120.0% |
| P/E (TTM) | -3.6 | 13.7 |
| P/B | 2.3 | 4.5 |
| P/E percentile vs own 5y | 34th | 41st |
| Dividend yield | – | 7.39% |
| Revenue growth (YoY, latest qtr) | – | +79.6% |
| Net profit growth (YoY) | +23.3% | +2,136.4% |
| Gross margin | – | 64.1% |
| Operating margin | – | 60.9% |
| Net margin | – | 31.4% |
| Return on equity | -50.3% | 32.7% |
| Analyst target vs. price | +213.4% | +23.1% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 32 | 38 |
| 30-day volatility | 100.3% | 46.1% |
| Max drawdown, 1 year | -52.9% | -22.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CGEM is the largest of the group by market value.
- HSHP has returned the most over the past year.
- CGEM carries the lowest trailing P/E.
- HSHP has been the calmest stock over the last 30 days.